Paper216448
N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver.
Aggerbeck M and 2 others. Br J Pharmacol, 1979. Cited by 14 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver. Papers, record 216448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/216448
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver | Major topic |
| Receptors, Adrenergic | Major topic |
| Receptors, Adrenergic, alpha | Major topic |
| Sympathomimetics | Major topic |
| Alkylation | |
| Animals | |
| Cell Membrane | |
| Dihydroergotoxine | |
| Female | |
| Rats | |
| Structure-Activity Relationship |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26,446 | Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors. | Br J Pharmacol | 1978 | https://conductscience.org/library/papers/26446 | PubMed |
| 2 | 191,710 | Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine. | Life Sci | 1977 | https://conductscience.org/library/papers/191710 | PubMed |
| 3 | 15,249 | Catecholamine binding to the beta-adrenergic receptor. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/15249 | PubMed |
| 4 | 21,422 | Potentiation of beta-sympathomimetics with alpha-adrenoceptor blocking drugs in guinea pig trachea and human bronchus preparations. | Pharmacology | 1977 | https://conductscience.org/library/papers/21422 | PubMed |
| 5 | 10,948 | A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/10948 | PubMed |
| 6 | 203,582 | Characterization with [3H] dihydroergocryptine of the alpha-adrenergic receptor of the hepatic plasma membrane. Comparison with the beta-adrenergic receptor in normal and adrenalectomized rats. | J Biol Chem | 1978 | https://conductscience.org/library/papers/203582 | PubMed |
| 7 | 195,950 | alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium efflux. | J Biol Chem | 1977 | https://conductscience.org/library/papers/195950 | PubMed |
| 8 | 825,511 | Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding. | J Biol Chem | 1976 | https://conductscience.org/library/papers/825511 | PubMed |
| 9 | 4,154,497 | Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site. | Science | 1974 | https://conductscience.org/library/papers/4154497 | PubMed |
| 10 | 180,428 | Transformation of the beta2 adrenoceptor in normal rat liver into a beta1 type in Zajdela hepatoma. | Nature | 1976 | https://conductscience.org/library/papers/180428 | PubMed |
| 11 | 4,894 | Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding. | Science | 1976 | https://conductscience.org/library/papers/4894 | PubMed |
| 12 | 4,202,581 | Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. | Biochem Pharmacol | 1973 | https://conductscience.org/library/papers/4202581 | PubMed |
| 13 | 4,967,807 | Isolation of an organ specific protein antigen from cell-surface membrane of rat liver. | Biochim Biophys Acta | 1968 | https://conductscience.org/library/papers/4967807 | PubMed |
| 14 | 5,342,360 | The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs. | Ann N Y Acad Sci | 1967 | https://conductscience.org/library/papers/5342360 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,298,278 | Adrenergic regulation of glycogenolysis in rat liver after cholestasis. Modulation of the balance between alpha 1 and beta 2 receptors. | J Clin Invest | 1983 | https://conductscience.org/library/papers/6298278 | PubMed |
| 6,119,625 | (+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/6119625 | PubMed |
| 2,908,732 | Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia. | Cardiovasc Drugs Ther | 1988 | https://conductscience.org/library/papers/2908732 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/216448
GET https://conductscience.org/api/papers/v1/216448/authors